In one paragraphArticle in The Journal of rheumatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors.
Hannah R ConcannonH.R. Concannon, SB, medical student, Duke University School of Medicine, Durham, North Carolina.ORCID 0009-0006-2362-749X Kai SunK. Sun MD, MS, J.L. Rogers, MD, M.E.B. Clowse, MD, MPH, M. Maheswaranathan, MD, L.G. Criscione-Schreiber, MD, MEd, N.J. Harris, MD, PhD, A.M. Eudy, PhD, Division of Rheumatology and Immunology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina.ORCID 0000-0002-8406-2932 Jennifer L RogersK. Sun MD, MS, J.L. Rogers, MD, M.E.B. Clowse, MD, MPH, M. Maheswaranathan, MD, L.G. Criscione-Schreiber, MD, MEd, N.J. Harris, MD, PhD, A.M. Eudy, PhD, Division of Rheumatology and Immunology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina.ORCID 0000-0003-1755-7684 Megan E B ClowseK. Sun MD, MS, J.L. Rogers, MD, M.E.B. Clowse, MD, MPH, M. Maheswaranathan, MD, L.G. Criscione-Schreiber, MD, MEd, N.J. Harris, MD, PhD, A.M. Eudy, PhD, Division of Rheumatology and Immunology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina.ORCID 0000-0002-8579-3470 Rachel L RandellR.L. Randell, MD, MSCR, Division of Pediatric Rheumatology, Department of Pediatrics, Duke University School of Medicine, Durham, North Carolina.ORCID 0000-0002-8009-8209 Mithu MaheswaranathanK. Sun MD, MS, J.L. Rogers, MD, M.E.B. Clowse, MD, MPH, M. Maheswaranathan, MD, L.G. Criscione-Schreiber, MD, MEd, N.J. Harris, MD, PhD, A.M. Eudy, PhD, Division of Rheumatology and Immunology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina.ORCID 0000-0003-0866-0022 Lisa G Criscione-SchreiberK. Sun MD, MS, J.L. Rogers, MD, M.E.B. Clowse, MD, MPH, M. Maheswaranathan, MD, L.G. Criscione-Schreiber, MD, MEd, N.J. Harris, MD, PhD, A.M. Eudy, PhD, Division of Rheumatology and Immunology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina.ORCID 0000-0003-3287-9251 Nathaniel J HarrisK. Sun MD, MS, J.L. Rogers, MD, M.E.B. Clowse, MD, MPH, M. Maheswaranathan, MD, L.G. Criscione-Schreiber, MD, MEd, N.J. Harris, MD, PhD, A.M. Eudy, PhD, Division of Rheumatology and Immunology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina.ORCID 0000-0001-9156-5979 Amanda M EudyK. Sun MD, MS, J.L. Rogers, MD, M.E.B. Clowse, MD, MPH, M. Maheswaranathan, MD, L.G. Criscione-Schreiber, MD, MEd, N.J. Harris, MD, PhD, A.M. Eudy, PhD, Division of Rheumatology and Immunology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina.ORCID 0000-0002-3107-5545 Rebecca E SadunR.E. Sadun, MD, PhD, Division of Rheumatology and Immunology, Department of Medicine, and Division of Pediatric Rheumatology, Department of Pediatrics, Duke University School of Medicine, Durham, North Carolina, USA. rebecca.sadun@duke.edu.ORCID 0000-0001-7768-3565 Funding
Interdisciplinary Research Careers in Women's HealthK12HD043446 · NICHD · DUKE UNIVERSITY · PI AMUNDSEN, CINDY · 2002 to 2023
$9.6MBuilding Interdisciplinary Research Careers in Women's Health (K12) - Administrative SupplementK12AR084231 · NIAMS · DUKE UNIVERSITY · PI Cindy Amundsen · 2023 to 2026
$2.5MDirect-to-family pharmacokinetics intervention for hydroxychloroquine non-adherence in adolescents with systemic lupus erythematosusK23AR084424 · NIAMS · DUKE UNIVERSITY · PI Rachel Leigh Randell · 2024 to 2026
$476kNIAMS NIH HHS K12 AR084231NIAMS NIH HHS K23 AR084424NICHD NIH HHS K12 HD043446
6 · The paper itselfAbstract
objectiveMedication adherence poses a challenge for young patients with systemic lupus erythematosus (SLE), who experience more active disease and damage than their older counterparts. This study aimed to quantify the rate of medication nonadherence by age and to identify differences in reasons for nonadherence between younger and older patients with SLE.
methodsWe collected responses to the Domains of Subjective Extent of Nonadherence (DOSE-Nonadherence)-SLE questionnaire, a clinical tool validated to measure extent of and reasons for medication nonadherence in SLE. Analysis included 336 surveys completed between February 2020 and June 2024. Proportions and odds ratios (ORs) for extent of and reasons for nonadherence were determined across age groups, and logistic regression was used to determine relationships of nonadherence with age and other covariates.
resultsMedication nonadherence differed significantly across age groups 18-29, 30-39, 40-49, and 50+ (
conclusionYounger patients reported greater extent of nonadherence, often due to logistical impediments. In addition to counseling young adults with SLE on the importance of medications, rheumatologists should, when possible, offer support to help them overcome challenges in obtaining and taking medicines. Approaches to understanding and intervening on medication nonadherence in SLE may need to be tailored by age.
Indexed as
Drug MonitoringLupus Erythematosus, SystemicMedication AdherenceAdolescentAdultAgedAge FactorsFemaleHumansMaleMiddle AgedSelf ReportSurveys and QuestionnairesYoung Adultage groupsassessment of medication adherencehealth services accessibilitymedication adherencesystemic lupus erythematosusyoung adult
Identifiers
PMID41771558
PMCPMC13015850
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390